Beginning October 1, 2024, Louisiana’s Act 246 will take effect. This legislation adds mifepristone and misoprostol to the Schedule IV list of controlled dangerous substances
The 2024 Louisiana legislative session came to an end on Monday, June 3rd, after 84 days of whirlwind policy debates, life-shattering legislation, and intense political maneuvering.